These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 30828537)

  • 1. A pH/ROS Cascade-Responsive Charge-Reversal Nanosystem with Self-Amplified Drug Release for Synergistic Oxidation-Chemotherapy.
    Dai L; Li X; Duan X; Li M; Niu P; Xu H; Cai K; Yang H
    Adv Sci (Weinh); 2019 Feb; 6(4):1801807. PubMed ID: 30828537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor-specific ROS self-supply enhanced cascade-responsive prodrug activation nanosystem for amplified chemotherapy against multidrug-resistant tumors.
    Wang J; Zhang H; Lv J; Zheng Y; Li M; Yang G; Wei X; Li N; Huang H; Li T; Qin X; Li S; Wu C; Zhang W; Liu Y; Yang H
    Acta Biomater; 2023 Jul; 164():522-537. PubMed ID: 37072069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy.
    Wang K; Xiao X; Liu Y; Zong Q; Tu Y; Yuan Y
    Biomaterials; 2022 Oct; 289():121803. PubMed ID: 36150300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
    Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
    Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
    Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
    Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy.
    Zhang X; Zhu T; Miao Y; Zhou L; Zhang W
    J Nanobiotechnology; 2020 Sep; 18(1):136. PubMed ID: 32972412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
    Chang N; Zhao Y; Ge N; Qian L
    Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tumor-Specific Cascade Amplification Drug Release Nanoparticle for Overcoming Multidrug Resistance in Cancers.
    Ye M; Han Y; Tang J; Piao Y; Liu X; Zhou Z; Gao J; Rao J; Shen Y
    Adv Mater; 2017 Oct; 29(38):. PubMed ID: 28833669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer.
    Wang K; Yang B; Ye H; Zhang X; Song H; Wang X; Li N; Wei L; Wang Y; Zhang H; Kan Q; He Z; Wang D; Sun J
    ACS Appl Mater Interfaces; 2019 May; 11(21):18914-18922. PubMed ID: 31055911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated block copolymer prodrug nanoparticles for combination of tumor oxidative stress amplification and ROS-responsive drug release.
    Yin W; Ke W; Chen W; Xi L; Zhou Q; Mukerabigwi JF; Ge Z
    Biomaterials; 2019 Mar; 195():63-74. PubMed ID: 30612064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-β blockade-improved chemo-immunotherapy with pH/ROS cascade-responsive micelle via tumor microenvironment remodeling.
    Dai L; Li X; Zheng X; Fu Z; Yao M; Meng S; Zhang J; Han B; Gao Q; Chang J; Cai K; Yang H
    Biomaterials; 2021 Sep; 276():121010. PubMed ID: 34247042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy.
    Li Y; Chen M; Yao B; Lu X; Song B; Vasilatos SN; Zhang X; Ren X; Yao C; Bian W; Sun L
    Small; 2020 Aug; 16(32):e2002188. PubMed ID: 32627387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy.
    Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z
    J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A ROS-responsive polymeric prodrug nanosystem with self-amplified drug release for PSMA (-) prostate cancer specific therapy.
    Wang Y; Zhang Y; Ru Z; Song W; Chen L; Ma H; Sun L
    J Nanobiotechnology; 2019 Aug; 17(1):91. PubMed ID: 31451114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmable prodrug micelle with size-shrinkage and charge-reversal for chemotherapy-improved IDO immunotherapy.
    Dai L; Li X; Yao M; Niu P; Yuan X; Li K; Chen M; Fu Z; Duan X; Liu H; Cai K; Yang H
    Biomaterials; 2020 May; 241():119901. PubMed ID: 32109706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-Triggered Disassembly of Polymeric Micelles by Controlled Depolymerization via Cascade Cyclization for Anticancer Drug Delivery.
    Park J; Jo S; Lee YM; Saravanakumar G; Lee J; Park D; Kim WJ
    ACS Appl Mater Interfaces; 2021 Feb; 13(7):8060-8070. PubMed ID: 33576220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An ROS-responsive artesunate prodrug nanosystem co-delivers dexamethasone for rheumatoid arthritis treatment through the HIF-1α/NF-κB cascade regulation of ROS scavenging and macrophage repolarization.
    Li Y; Liang Q; Zhou L; Cao Y; Yang J; Li J; Liu J; Bi J; Liu Y
    Acta Biomater; 2022 Oct; 152():406-424. PubMed ID: 36055613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor Microenvironment Cascade-Responsive Nanodrug with Self-Targeting Activation and ROS Regeneration for Synergistic Oxidation-Chemotherapy.
    Li Y; Lin J; Wang P; Luo Q; Zhu F; Zhang Y; Hou Z; Liu X; Liu J
    Nanomicro Lett; 2020 Sep; 12(1):182. PubMed ID: 34138172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-Responsive Micellar Nanoparticles for the Delivery of a Self-Amplifying ROS-Activatable Prodrug.
    Kannaujiya VK; Qiao Y; Sheikh RH; Xue J; Dargaville TR; Liang K; Wich PR
    Biomacromolecules; 2024 Mar; 25(3):1775-1789. PubMed ID: 38377594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual pH-responsive-charge-reversal micelle platform for enhanced anticancer therapy.
    Liao J; Peng H; Liu C; Li D; Yin Y; Lu B; Zheng H; Wang Q
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111527. PubMed ID: 33255080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.